Atlas Trials

Hereditary Breast and Ovarian Cancer Syndrome

22 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hereditary Breast and Ovarian Cancer Syndrome

RecordFirmDate
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI (NCT06892275)Georgetown University2025-06-01
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention (NCT05677048)M.D. Anderson Cancer Center2023-04-14
Pediatric Reporting of Adult-Onset Genomic Results (NCT03832985)Geisinger Clinic2020-11-25
Enhance the Use of Genetic Counseling and Testing in Latinas (NCT04544501)Georgetown University2020-02-24
Direct Information to At-risk Relatives (NCT04197856)Umeå University2020-02-06
Tissue Expansion in Breast Reconstruction Without Drains (NCT03784859)Cedars-Sinai Medical Center2019-02-25
Risk-Reducing Surgeries for Hereditary Ovarian Cancer (NCT03294343)Lei Li2017-09-01
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers (NCT03162276)Sheba Medical Center2017-07-01
Inherited Susceptible Genes Among Epithelial Ovarian Cancer (NCT03015376)Peking Union Medical College Hospital2017-01-01
Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations (NCT02760849)M.D. Anderson Cancer Center2016-05-02
Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk (NCT02705924)Centre Jean Perrin2016-04-01
Women at Risk of Breast Cancer and OLFM4 (NCT02653105)Institut Cancerologie de l'Ouest2016-03-08
Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands (NCT07039552)Peking University Third Hospital2016-01-01
Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study (NCT02562170)Medical University of Vienna2013-07-01
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers (NCT01367639)Sheba Medical Center2011-03-01
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 (NCT01445275)Gynecologic Oncology Group2011-01-01
Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer (NCT01333748)Centre Francois Baclesse2010-04-01
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy (NCT00892736)National Cancer Institute (NCI)2009-04-20
Telemedicine vs. Face-to-Face Cancer Genetic Counseling (NCT00609505)Duke University2008-08-01
Statewide Communication to Reach Diverse Low Income Women (NCT02956681)University of California, San Francisco2007-10-01
Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer (NCT00535119)National Cancer Institute (NCI)2007-09-01
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries (NCT00305695)Gynecologic Oncology Group2005-11-28

Track Hereditary Breast and Ovarian Cancer Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.